Dyax Corp
Industry
- Pharmaceuticals
- Biotechnology
- Drug Discovery Technologies
- Molecular Diversity
- Large Molecule
- Antibodies
- Drug Discovery Technologies
Latest on Dyax Corp
Historical Irrationality The public market for biotech stocks is notoriously volatile. Retail and generalist investors may become confused or react irrationally when a small biotech company releases “
Although family-owned Boehringer Ingelheim GmbH is the only private firm in the top 20 largest biopharmas, its executives are quick to explain that most of their operations function in the same way
Hereditary angioedema (HAE) is a rare condition and listed in China’s official National Rare Disease List, issued in 2018. On 7 December, a new option for the autosomal dominant genetic disease was ap
Here's your news in brief from the land of reviews and approvals: Celgene Corp. has suffered yet another setback, as the US FDA has refused to file a new drug application (NDA) for its multiple scle